找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Epidemiologic Research on Real-World Medical Data in Japan; Volume 2 Naoki Nakashima Book 2022 The Editor(s) (if applicable) and The Author

[復制鏈接]
樓主: ARGOT
11#
發(fā)表于 2025-3-23 11:35:51 | 只看該作者
So gesund, wie ein kleines Steak...,In Standardized Structured Medical Information eXchange 2 (SS-MIX2), the standard contract in Electronic Data Capture (EDC) of Japan, HOT code is specified as the standard code of drug.
12#
發(fā)表于 2025-3-23 16:20:40 | 只看該作者
13#
發(fā)表于 2025-3-23 20:02:15 | 只看該作者
Lindy Clemson,Jo Munro,Clemens BeckerWhen using data from medical records, disease conditions and patient information that are not clearly described must be determined. For example, even if the clinical information for the medical treatment fee is accurately described in the administrative claims data, it does not always precisely indicate the medical condition of a patient.
14#
發(fā)表于 2025-3-24 01:31:15 | 只看該作者
15#
發(fā)表于 2025-3-24 04:24:57 | 只看該作者
Wilfried J. Elspass,Manfred Flemming em.The mainstream of clinical research designs has been the . (RCT). In an RCT, two or more distinct interventions are randomly assigned to participating patients who have met strict eligibility criteria, with the patients’ outcomes followed-up and compared between the intervention groups.
16#
發(fā)表于 2025-3-24 08:26:44 | 只看該作者
17#
發(fā)表于 2025-3-24 12:05:34 | 只看該作者
Real World Medical Data and Clinical Pathway in JapanClinical pathways (CP) were developed by Karen Zander et al. in the 1980s. CP were epoch-making in the sense that traditional critical pathways used in engineering were applied to medical treatment.
18#
發(fā)表于 2025-3-24 15:34:38 | 只看該作者
19#
發(fā)表于 2025-3-24 19:00:51 | 只看該作者
20#
發(fā)表于 2025-3-25 02:22:53 | 只看該作者
Data Quality Governance Experience at the MID-NET ProjectRecently, with the widespread implementation of “Real-World Data (RWD),” there is increasing interest in using high-quality administrative claims, laboratory tests, electronic health records (EHRs), and information-sharing resources to enhance detection of serious adverse drug reactions (ADRs).
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-16 13:45
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
巴中市| 克山县| 彝良县| 扶绥县| 九龙县| 靖安县| 洮南市| 富平县| 湖北省| 呼图壁县| 郧西县| 栾川县| 香河县| 筠连县| 巩留县| 集贤县| 垣曲县| 通辽市| 罗定市| 彝良县| 陆河县| 永州市| 宜阳县| 新河县| 湘西| 会理县| 开阳县| 炉霍县| 铅山县| 文昌市| 寿宁县| 崇礼县| 仁布县| 晋江市| 铜川市| 宝清县| 麻江县| 杭州市| 永昌县| 安阳县| 郁南县|